A photo of J. Pablo Abonia.

Associate Professor, UC Department of Pediatrics

513-636-9728

513-636-3310

Board Certified

Make an Appointment

"When I care for my patients, I always put them first, with the goal of identifying their problems and working to resolve them."

My Biography & Research

Biography

I’m an allergist who specializes in treating children with eosinophilic gastrointestinal disorders, eosinophilic esophagitis, eosinophilia, mast cell disorders and urticaria. My research focuses on finding the most effective therapies for patients with eosinophilic and mast cell disorders.

Seeing my father work as a pediatrician inspired me to follow in his footsteps and choose medicine as a profession. I completed my formal pediatric training at Children’s Hospital of Buffalo and my allergy and immunology training at Brigham and Women’s Hospital in Boston. These experiences provided the education, skills and resources that prepared me to help my patients as a member of the Cincinnati Center for Eosinophilic Disorders (CCED).

When I care for my patients, I always put them first, with the goal of identifying their problems and working to resolve them. I strive to improve control of their symptoms. In my research, I work toward long-term control of diseases related to eosinophilic disorders and mast cell disease. I’ve published a number of journal articles in my field, and I am involved in multicenter clinical trials for eosinophilic disorders.

I was previously the interim director of the Registry for Eosinophilic Disorders. I presented the Joseph E. Ghory, MD, Memorial Lectureship for the Ohio Society of Allergy, Asthma, and Immunology; the 15th Annual Dr. John M. Karibo Memorial Lectureship; and at other national meetings related to eosinophilic and mast cell disorders. I’m also proud to be named one of Cincinnati Magazine’s Top Doctors.

Outside of the hospital, I enjoy spending time with my wife and family.

Additional Languages

Spanish

Clinical Interests

Immunodeficiency

Research Interests

Mast cell progenitor homing / recruitment and its involvement in allergic disorders

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Allergy and Immunology, Eosinophilic Disorders

Research Divisions

Allergy and Immunology, Eosinophilic Disorders

My Locations

My Education

MD: University of Buffalo, Buffalo, NY, 1997.

Residency: Pediatrics, Children's Hospital of Buffalo, Buffalo, NY, 2000.

Certification: American Board of Pediatrics, 2001; American Board of Allergy and Immunology, 2003.

My Publications

Type 2 Immunity and Age Modify Gene Expression of COVID19 Receptors in Eosinophilic Gastrointestinal Disorders. Chiang, AW T; Duong, LD; Shoda, T; Nhu, QM; Ruffner, M; Hara, T; Aaron, B; Joplin, E; Manresa, M; Abonia, JP; et al. Journal of Pediatric Gastroenterology and Nutrition. 2020; Publish Ahead of Print.

High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases. Jensen, ET; Aceves, SS; Bonis, PA; Bray, K; Book, W; Chehade, M; Collins, MH; Dellon, ES; Falk, GW; Gonsalves, N; et al. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:524-529.

Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine. Slack, IF; Schwartz, JT; Mukkada, VA; Hottinger, S; Abonia, JP. Current Allergy and Asthma Reports. 2020; 20.

Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis. Azouz, NP; Klingler, AM; Pathre, P; Besse, JA; Ben Baruch-Morgenstern, N; Ballaban, AY; Osswald, GA; Brusilovsky, M; Habel, JE; Caldwell, JM; et al. Science Translational Medicine. 2020; 12:eaaz7773-eaaz7773.

Eosinophilic Esophagitis Histology Remission Score: Significant Relations to Measures of Disease Activity and Symptoms. Collins, MH; Martin, LJ; Wen, T; Abonia, JP; Putnam, PE; Mukkada, VA; Rothenberg, ME. Journal of Pediatric Gastroenterology and Nutrition. 2020; 70:598-603.

Monitoring Eosinophilic Esophagitis Disease Activity With Blood Eosinophil Progenitor Levels. Henderson, A; Magier, A; Schwartz, JT; Martin, LJ; Collins, MH; Putnam, PE; Mukkada, VA; Abonia, JP; Rothenberg, ME; Fulkerson, PC. Journal of Pediatric Gastroenterology and Nutrition. 2020; 70:482-488.

Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study. Shoda, T; Wen, T; Caldwell, JM; Collins, MH; Besse, JA; Osswald, GA; Abonia, JP; Arva, NC; MDd, DA; Capocelli, KE; et al. Journal of Allergy and Clinical Immunology. 2020; 145:255-269.

Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Aceves, S; Collins, MH; Rothenberg, ME; Furuta, GT; Gonsalves, N; Abonia, JP; Almonte, S; Andrews, R; Arrington, A; Arva, N; et al. Journal of Allergy and Clinical Immunology. 2020; 145:28-37.

Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis. Kottyan, LC; Maddox, A; Braxton, JR; Stucke, EM; Mukkada, V; Putnam, PE; Abonia, JP; Chehade, M; Wood, RA; Pesek, RD; et al. Genes and Immunity. 2019; 20:281-292.

Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration Why Was the Consortium of Eosinophilic Gastrointestinal Disease Researchers Established?. Gupta, SK; Falk, GW; Aceves, SS; Chehade, M; Collins, MH; Dellon, ES; Gonsalves, N; Hirano, I; Mukkuda, VA; Peterson, KA; et al. Gastroenterology. 2019; 156:838-842.